Eloxx Pharmaceuticals, Inc (ELOX) Stock Price

15.75 ▼ -0.53 (-3.26%)
Open: 16.74 Vol: 17.13K Day's range: 15.00 - 17.19 Sep 11, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ELOX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 15.44▼ 15.54▼ 15.70▼ 15.95▼ 17.11▼
MA10 15.37▲ 15.78▼ 15.93▼ 15.66▲ 15.63▲
MA20 15.61▼ 16.10▼ 16.07▼ 17.16▼ 17.95▼
MA50 15.98▼ 15.64▼ 15.57▼ 15.30▲ 42.95▼
MA100 15.69▼ 15.90▼ 17.08▼ 22.15▼ 72.68▼
MA200 15.65▼ 17.41▼ 16.45▼ 43.92▼ 536.59▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.002▲ -0.142▼ -0.114▼ -0.237▼ 1.606▲
RSI 45.141▼ 42.561▼ 44.116▼ 47.046▼ 39.811▼
STOCH 45.055     20.457     17.356▼ 39.684     59.664    
WILL %R -58.108     -81.098▼ -81.548▼ -74.578     -57.089    
CCI 14.493     -115.321▼ -152.681▼ -36.213     35.130    
Latest Filters Detected On ELOX
▲ GAP $ELOX Open Gap Up %2 Set Alert
Eloxx Pharmaceuticals, Inc News
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
Friday, September 11, 2026 04:30 AM
Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases, today announced that the first two patients have ...
Eloxx Pharmaceuticals, Inc.: Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
Friday, September 11, 2026 01:02 AM
First two patients dosed in the EXACT study Topline data from the initial 16-week placebo-controlled portion of the study expected mid-2027; final readout expected ...
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Wednesday, August 12, 2026 03:00 AM
ARLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases, ...
ELOX historical stock data
date open high low close volume
11/09/26 16.74 17.19 15.00 15.75 17,131
10/09/26 16.50 17.15 15.745 16.28 28,686
09/09/26 16.03 17.74 15.16 16.57 37,439
08/09/26 15.49 17.42 15.0001 16.17 29,178
04/09/26 14.06 16.48 14.06 15.00 38,840
03/09/26 15.98 16.975 13.79 14.19 37,405
02/09/26 14.80 16.50 14.71 15.84 57,779
01/09/26 16.81 16.81 15.01 15.01 34,077
31/08/26 14.20 17.325 13.9327 16.77 38,820
28/08/26 16.22 16.65 15.07 15.07 32,102
Quote Details
52wk Low:10.00
52wk High:119.90
Vol:17.13K
Avg Vol(3m):955.1K
1Y Chng:-58.97%
1M Chng:-9.64%
Add to Watch List
More Information
Index N/A
Market Cap. 55.94M